Global Artificial Intelligence (AI) in Drug Discovery Market

Artificial Intelligence (AI) in Drug Discovery Comprehensive Study by Application (Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Other Applications), Technology (Machine Learning, Deep Learning, Supervised Learning, Reinforcement Learning, Unsupervised Learning, Others), End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes), Offering (Software, Services) Players and Region - Global Market Outlook to 2024

Artificial Intelligence (AI) in Drug Discovery Market by XX Submarkets | Forecast Years 2021-2026 | CAGR: 38.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Artificial intelligence (AI) has become a crucial part of the technological infrastructure. Key players in the healthcare technology market are transitioning their product portfolio to include AI technology which is acting as a major growth factor of the market. AI can improve efficiency and outcomes in drug development across therapeutic areas along with reducing the cost of drug development. Major players in the market are IBM, Google, Microsoft, NVIDIA, and others. Rapid growth in cases of rare diseases, as well as demand for a personalized drug, will help to boost global AI in the drug discovery market. In addition, rising adoption of cloud-based applications and rising demand from developing economies such as India, China, Japan, and others expected to fuel the growth of AI in the Drug Discovery market during the forecasted period.According to AMA, the market for Artificial Intelligence (AI) in Drug Discovery is expected to register a CAGR of 38.3% during the forecast period to 2024. This growth is primarily driven by Increasing Importance of Precision Medicine and Growing Adoption of Cloud-Based Applications and Services.

Globally, a noticeable market trend is evident Increasing Number of Cross-Industry Collaborations . Major Players, such as IBM Corporation (United States), Microsoft (United States), Google (United States), NVIDIA Corporation (United States), Atomwise, Inc. (United States), Deep Genomics (Canada), Cloud Pharmaceuticals (United States), Insilico Medicine (United States), BenevolentAI (United Kingdom), Exscientia (United Kingdom), Cyclica (Canada), BIOAGE (United States), Numerate (United States) and NuMedii (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On 30th May 2018, GSK collaborated with Cloud Pharmaceutical, an Artificial Intelligence-driven drug design, and Development Company for AI-driven drug design. The company is set to apply artificial intelligence technology to improve its drug discovery efforts through a collaboration with Cloud Pharmaceuticals.

Regulatory Insights:
“The Food and Drug Administration announced that it is developing a framework for regulating artificial intelligence products used in medicine that continually adapt based on new data. A new approach to these technologies would address the need for the algorithms to learn and adapt when used in the real world.”

Market Drivers
  • Increasing Importance of Precision Medicine
  • Growing Adoption of Cloud-Based Applications and Services

Market Trend
  • Increasing Number of Cross-Industry Collaborations
  • Emphasizing on Technological Advancement in the Healthcare Industry

Restraints
  • Stringent Government Regulations Regarding Integration of AI in Drug Discovery
  • Limited Availability of Datasets in the Field of Drug Discovery

Opportunities
Growth in Biotechnology Industry and Untapped Market in Developing Regions
Challenges
Lack of Awareness in the Emerging Economies

AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Application
  • Immuno-oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Other Applications
By Technology
  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Others

By End-User
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Research Centers and Academic & Government Institutes

By Offering
  • Software
  • Services

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Importance of Precision Medicine
      • 3.2.2. Growing Adoption of Cloud-Based Applications and Services
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness in the Emerging Economies
    • 3.4. Market Trends
      • 3.4.1. Increasing Number of Cross-Industry Collaborations
      • 3.4.2. Emphasizing on Technological Advancement in the Healthcare Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Intelligence (AI) in Drug Discovery, by Application, Technology, End-User, Offering and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Artificial Intelligence (AI) in Drug Discovery (Value)
      • 5.2.1. Global Artificial Intelligence (AI) in Drug Discovery by: Application (Value)
        • 5.2.1.1. Immuno-oncology
        • 5.2.1.2. Neurodegenerative Diseases
        • 5.2.1.3. Cardiovascular Diseases
        • 5.2.1.4. Metabolic Diseases
        • 5.2.1.5. Other Applications
      • 5.2.2. Global Artificial Intelligence (AI) in Drug Discovery by: Technology (Value)
        • 5.2.2.1. Machine Learning
        • 5.2.2.2. Deep Learning
        • 5.2.2.3. Supervised Learning
        • 5.2.2.4. Reinforcement Learning
        • 5.2.2.5. Unsupervised Learning
        • 5.2.2.6. Others
      • 5.2.3. Global Artificial Intelligence (AI) in Drug Discovery by: End-User (Value)
        • 5.2.3.1. Pharmaceutical & Biotechnology Companies
        • 5.2.3.2. Contract Research Organizations
        • 5.2.3.3. Research Centers and Academic & Government Institutes
      • 5.2.4. Global Artificial Intelligence (AI) in Drug Discovery by: Offering (Value)
        • 5.2.4.1. Software
        • 5.2.4.2. Services
      • 5.2.5. Global Artificial Intelligence (AI) in Drug Discovery Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Artificial Intelligence (AI) in Drug Discovery: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. IBM Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Microsoft (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Google (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. NVIDIA Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Atomwise, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Deep Genomics (Canada)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cloud Pharmaceuticals (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Insilico Medicine (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. BenevolentAI (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Exscientia (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Cyclica (Canada)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. BIOAGE (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Numerate (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. NuMedii (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Artificial Intelligence (AI) in Drug Discovery Sale, by Application, Technology, End-User, Offering and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Artificial Intelligence (AI) in Drug Discovery (Value)
      • 7.2.1. Global Artificial Intelligence (AI) in Drug Discovery by: Application (Value)
        • 7.2.1.1. Immuno-oncology
        • 7.2.1.2. Neurodegenerative Diseases
        • 7.2.1.3. Cardiovascular Diseases
        • 7.2.1.4. Metabolic Diseases
        • 7.2.1.5. Other Applications
      • 7.2.2. Global Artificial Intelligence (AI) in Drug Discovery by: Technology (Value)
        • 7.2.2.1. Machine Learning
        • 7.2.2.2. Deep Learning
        • 7.2.2.3. Supervised Learning
        • 7.2.2.4. Reinforcement Learning
        • 7.2.2.5. Unsupervised Learning
        • 7.2.2.6. Others
      • 7.2.3. Global Artificial Intelligence (AI) in Drug Discovery by: End-User (Value)
        • 7.2.3.1. Pharmaceutical & Biotechnology Companies
        • 7.2.3.2. Contract Research Organizations
        • 7.2.3.3. Research Centers and Academic & Government Institutes
      • 7.2.4. Global Artificial Intelligence (AI) in Drug Discovery by: Offering (Value)
        • 7.2.4.1. Software
        • 7.2.4.2. Services
      • 7.2.5. Global Artificial Intelligence (AI) in Drug Discovery Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Intelligence (AI) in Drug Discovery: by Application(USD Million)
  • Table 2. Artificial Intelligence (AI) in Drug Discovery Immuno-oncology , by Region USD Million (2013-2018)
  • Table 3. Artificial Intelligence (AI) in Drug Discovery Neurodegenerative Diseases , by Region USD Million (2013-2018)
  • Table 4. Artificial Intelligence (AI) in Drug Discovery Cardiovascular Diseases , by Region USD Million (2013-2018)
  • Table 5. Artificial Intelligence (AI) in Drug Discovery Metabolic Diseases , by Region USD Million (2013-2018)
  • Table 6. Artificial Intelligence (AI) in Drug Discovery Other Applications , by Region USD Million (2013-2018)
  • Table 7. Artificial Intelligence (AI) in Drug Discovery: by Technology(USD Million)
  • Table 8. Artificial Intelligence (AI) in Drug Discovery Machine Learning , by Region USD Million (2013-2018)
  • Table 9. Artificial Intelligence (AI) in Drug Discovery Deep Learning , by Region USD Million (2013-2018)
  • Table 10. Artificial Intelligence (AI) in Drug Discovery Supervised Learning , by Region USD Million (2013-2018)
  • Table 11. Artificial Intelligence (AI) in Drug Discovery Reinforcement Learning , by Region USD Million (2013-2018)
  • Table 12. Artificial Intelligence (AI) in Drug Discovery Unsupervised Learning , by Region USD Million (2013-2018)
  • Table 13. Artificial Intelligence (AI) in Drug Discovery Others , by Region USD Million (2013-2018)
  • Table 14. Artificial Intelligence (AI) in Drug Discovery: by End-User(USD Million)
  • Table 15. Artificial Intelligence (AI) in Drug Discovery Pharmaceutical & Biotechnology Companies , by Region USD Million (2013-2018)
  • Table 16. Artificial Intelligence (AI) in Drug Discovery Contract Research Organizations , by Region USD Million (2013-2018)
  • Table 17. Artificial Intelligence (AI) in Drug Discovery Research Centers and Academic & Government Institutes , by Region USD Million (2013-2018)
  • Table 18. Artificial Intelligence (AI) in Drug Discovery: by Offering(USD Million)
  • Table 19. Artificial Intelligence (AI) in Drug Discovery Software , by Region USD Million (2013-2018)
  • Table 20. Artificial Intelligence (AI) in Drug Discovery Services , by Region USD Million (2013-2018)
  • Table 21. South America Artificial Intelligence (AI) in Drug Discovery, by Country USD Million (2013-2018)
  • Table 22. South America Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 23. South America Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 24. South America Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 25. South America Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 26. Brazil Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 27. Brazil Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 28. Brazil Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 29. Brazil Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 30. Argentina Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 31. Argentina Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 32. Argentina Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 33. Argentina Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 34. Rest of South America Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 35. Rest of South America Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 36. Rest of South America Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 37. Rest of South America Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 38. Asia Pacific Artificial Intelligence (AI) in Drug Discovery, by Country USD Million (2013-2018)
  • Table 39. Asia Pacific Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 40. Asia Pacific Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 41. Asia Pacific Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 42. Asia Pacific Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 43. China Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 44. China Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 45. China Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 46. China Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 47. Japan Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 48. Japan Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 49. Japan Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 50. Japan Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 51. India Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 52. India Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 53. India Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 54. India Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 55. South Korea Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 56. South Korea Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 57. South Korea Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 58. South Korea Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 59. Taiwan Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 60. Taiwan Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 61. Taiwan Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 62. Taiwan Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 63. Australia Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 64. Australia Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 65. Australia Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 66. Australia Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 67. Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 68. Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 69. Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 70. Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 71. Europe Artificial Intelligence (AI) in Drug Discovery, by Country USD Million (2013-2018)
  • Table 72. Europe Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 73. Europe Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 74. Europe Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 75. Europe Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 76. Germany Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 77. Germany Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 78. Germany Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 79. Germany Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 80. France Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 81. France Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 82. France Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 83. France Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 84. Italy Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 85. Italy Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 86. Italy Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 87. Italy Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 88. United Kingdom Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 89. United Kingdom Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 90. United Kingdom Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 91. United Kingdom Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 92. Netherlands Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 93. Netherlands Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 94. Netherlands Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 95. Netherlands Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 96. Rest of Europe Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 97. Rest of Europe Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 98. Rest of Europe Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 99. Rest of Europe Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 100. MEA Artificial Intelligence (AI) in Drug Discovery, by Country USD Million (2013-2018)
  • Table 101. MEA Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 102. MEA Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 103. MEA Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 104. MEA Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 105. Middle East Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 106. Middle East Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 107. Middle East Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 108. Middle East Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 109. Africa Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 110. Africa Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 111. Africa Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 112. Africa Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 113. North America Artificial Intelligence (AI) in Drug Discovery, by Country USD Million (2013-2018)
  • Table 114. North America Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 115. North America Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 116. North America Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 117. North America Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 118. United States Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 119. United States Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 120. United States Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 121. United States Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 122. Canada Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 123. Canada Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 124. Canada Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 125. Canada Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 126. Mexico Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2013-2018)
  • Table 127. Mexico Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2013-2018)
  • Table 128. Mexico Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2013-2018)
  • Table 129. Mexico Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2013-2018)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Artificial Intelligence (AI) in Drug Discovery: by Application(USD Million)
  • Table 145. Artificial Intelligence (AI) in Drug Discovery Immuno-oncology , by Region USD Million (2019-2024)
  • Table 146. Artificial Intelligence (AI) in Drug Discovery Neurodegenerative Diseases , by Region USD Million (2019-2024)
  • Table 147. Artificial Intelligence (AI) in Drug Discovery Cardiovascular Diseases , by Region USD Million (2019-2024)
  • Table 148. Artificial Intelligence (AI) in Drug Discovery Metabolic Diseases , by Region USD Million (2019-2024)
  • Table 149. Artificial Intelligence (AI) in Drug Discovery Other Applications , by Region USD Million (2019-2024)
  • Table 150. Artificial Intelligence (AI) in Drug Discovery: by Technology(USD Million)
  • Table 151. Artificial Intelligence (AI) in Drug Discovery Machine Learning , by Region USD Million (2019-2024)
  • Table 152. Artificial Intelligence (AI) in Drug Discovery Deep Learning , by Region USD Million (2019-2024)
  • Table 153. Artificial Intelligence (AI) in Drug Discovery Supervised Learning , by Region USD Million (2019-2024)
  • Table 154. Artificial Intelligence (AI) in Drug Discovery Reinforcement Learning , by Region USD Million (2019-2024)
  • Table 155. Artificial Intelligence (AI) in Drug Discovery Unsupervised Learning , by Region USD Million (2019-2024)
  • Table 156. Artificial Intelligence (AI) in Drug Discovery Others , by Region USD Million (2019-2024)
  • Table 157. Artificial Intelligence (AI) in Drug Discovery: by End-User(USD Million)
  • Table 158. Artificial Intelligence (AI) in Drug Discovery Pharmaceutical & Biotechnology Companies , by Region USD Million (2019-2024)
  • Table 159. Artificial Intelligence (AI) in Drug Discovery Contract Research Organizations , by Region USD Million (2019-2024)
  • Table 160. Artificial Intelligence (AI) in Drug Discovery Research Centers and Academic & Government Institutes , by Region USD Million (2019-2024)
  • Table 161. Artificial Intelligence (AI) in Drug Discovery: by Offering(USD Million)
  • Table 162. Artificial Intelligence (AI) in Drug Discovery Software , by Region USD Million (2019-2024)
  • Table 163. Artificial Intelligence (AI) in Drug Discovery Services , by Region USD Million (2019-2024)
  • Table 164. South America Artificial Intelligence (AI) in Drug Discovery, by Country USD Million (2019-2024)
  • Table 165. South America Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 166. South America Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 167. South America Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 168. South America Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 169. Brazil Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 170. Brazil Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 171. Brazil Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 172. Brazil Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 173. Argentina Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 174. Argentina Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 175. Argentina Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 176. Argentina Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 177. Rest of South America Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 178. Rest of South America Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 179. Rest of South America Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 180. Rest of South America Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 181. Asia Pacific Artificial Intelligence (AI) in Drug Discovery, by Country USD Million (2019-2024)
  • Table 182. Asia Pacific Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 183. Asia Pacific Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 184. Asia Pacific Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 185. Asia Pacific Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 186. China Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 187. China Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 188. China Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 189. China Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 190. Japan Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 191. Japan Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 192. Japan Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 193. Japan Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 194. India Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 195. India Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 196. India Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 197. India Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 198. South Korea Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 199. South Korea Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 200. South Korea Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 201. South Korea Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 202. Taiwan Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 203. Taiwan Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 204. Taiwan Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 205. Taiwan Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 206. Australia Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 207. Australia Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 208. Australia Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 209. Australia Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 210. Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 211. Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 212. Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 213. Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 214. Europe Artificial Intelligence (AI) in Drug Discovery, by Country USD Million (2019-2024)
  • Table 215. Europe Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 216. Europe Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 217. Europe Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 218. Europe Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 219. Germany Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 220. Germany Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 221. Germany Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 222. Germany Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 223. France Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 224. France Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 225. France Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 226. France Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 227. Italy Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 228. Italy Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 229. Italy Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 230. Italy Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 231. United Kingdom Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 232. United Kingdom Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 233. United Kingdom Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 234. United Kingdom Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 235. Netherlands Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 236. Netherlands Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 237. Netherlands Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 238. Netherlands Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 239. Rest of Europe Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 240. Rest of Europe Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 241. Rest of Europe Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 242. Rest of Europe Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 243. MEA Artificial Intelligence (AI) in Drug Discovery, by Country USD Million (2019-2024)
  • Table 244. MEA Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 245. MEA Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 246. MEA Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 247. MEA Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 248. Middle East Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 249. Middle East Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 250. Middle East Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 251. Middle East Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 252. Africa Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 253. Africa Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 254. Africa Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 255. Africa Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 256. North America Artificial Intelligence (AI) in Drug Discovery, by Country USD Million (2019-2024)
  • Table 257. North America Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 258. North America Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 259. North America Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 260. North America Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 261. United States Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 262. United States Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 263. United States Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 264. United States Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 265. Canada Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 266. Canada Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 267. Canada Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 268. Canada Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 269. Mexico Artificial Intelligence (AI) in Drug Discovery, by Application USD Million (2019-2024)
  • Table 270. Mexico Artificial Intelligence (AI) in Drug Discovery, by Technology USD Million (2019-2024)
  • Table 271. Mexico Artificial Intelligence (AI) in Drug Discovery, by End-User USD Million (2019-2024)
  • Table 272. Mexico Artificial Intelligence (AI) in Drug Discovery, by Offering USD Million (2019-2024)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Intelligence (AI) in Drug Discovery: by Application USD Million (2013-2018)
  • Figure 5. Global Artificial Intelligence (AI) in Drug Discovery: by Technology USD Million (2013-2018)
  • Figure 6. Global Artificial Intelligence (AI) in Drug Discovery: by End-User USD Million (2013-2018)
  • Figure 7. Global Artificial Intelligence (AI) in Drug Discovery: by Offering USD Million (2013-2018)
  • Figure 8. South America Artificial Intelligence (AI) in Drug Discovery Share (%), by Country
  • Figure 9. Asia Pacific Artificial Intelligence (AI) in Drug Discovery Share (%), by Country
  • Figure 10. Europe Artificial Intelligence (AI) in Drug Discovery Share (%), by Country
  • Figure 11. MEA Artificial Intelligence (AI) in Drug Discovery Share (%), by Country
  • Figure 12. North America Artificial Intelligence (AI) in Drug Discovery Share (%), by Country
  • Figure 13. Global Artificial Intelligence (AI) in Drug Discovery share by Players 2018 (%)
  • Figure 14. Global Artificial Intelligence (AI) in Drug Discovery share by Players (Top 3) 2018(%)
  • Figure 15. Global Artificial Intelligence (AI) in Drug Discovery share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. IBM Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. IBM Corporation (United States) Revenue: by Geography 2018
  • Figure 19. Microsoft (United States) Revenue, Net Income and Gross profit
  • Figure 20. Microsoft (United States) Revenue: by Geography 2018
  • Figure 21. Google (United States) Revenue, Net Income and Gross profit
  • Figure 22. Google (United States) Revenue: by Geography 2018
  • Figure 23. NVIDIA Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. NVIDIA Corporation (United States) Revenue: by Geography 2018
  • Figure 25. Atomwise, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Atomwise, Inc. (United States) Revenue: by Geography 2018
  • Figure 27. Deep Genomics (Canada) Revenue, Net Income and Gross profit
  • Figure 28. Deep Genomics (Canada) Revenue: by Geography 2018
  • Figure 29. Cloud Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cloud Pharmaceuticals (United States) Revenue: by Geography 2018
  • Figure 31. Insilico Medicine (United States) Revenue, Net Income and Gross profit
  • Figure 32. Insilico Medicine (United States) Revenue: by Geography 2018
  • Figure 33. BenevolentAI (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. BenevolentAI (United Kingdom) Revenue: by Geography 2018
  • Figure 35. Exscientia (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Exscientia (United Kingdom) Revenue: by Geography 2018
  • Figure 37. Cyclica (Canada) Revenue, Net Income and Gross profit
  • Figure 38. Cyclica (Canada) Revenue: by Geography 2018
  • Figure 39. BIOAGE (United States) Revenue, Net Income and Gross profit
  • Figure 40. BIOAGE (United States) Revenue: by Geography 2018
  • Figure 41. Numerate (United States) Revenue, Net Income and Gross profit
  • Figure 42. Numerate (United States) Revenue: by Geography 2018
  • Figure 43. NuMedii (United States) Revenue, Net Income and Gross profit
  • Figure 44. NuMedii (United States) Revenue: by Geography 2018
  • Figure 45. Global Artificial Intelligence (AI) in Drug Discovery: by Application USD Million (2019-2024)
  • Figure 46. Global Artificial Intelligence (AI) in Drug Discovery: by Technology USD Million (2019-2024)
  • Figure 47. Global Artificial Intelligence (AI) in Drug Discovery: by End-User USD Million (2019-2024)
  • Figure 48. Global Artificial Intelligence (AI) in Drug Discovery: by Offering USD Million (2019-2024)
  • Figure 49. South America Artificial Intelligence (AI) in Drug Discovery Share (%), by Country
  • Figure 50. Asia Pacific Artificial Intelligence (AI) in Drug Discovery Share (%), by Country
  • Figure 51. Europe Artificial Intelligence (AI) in Drug Discovery Share (%), by Country
  • Figure 52. MEA Artificial Intelligence (AI) in Drug Discovery Share (%), by Country
  • Figure 53. North America Artificial Intelligence (AI) in Drug Discovery Share (%), by Country
List of companies from research coverage that are profiled in the study
  • IBM Corporation (United States)
  • Microsoft (United States)
  • Google (United States)
  • NVIDIA Corporation (United States)
  • Atomwise, Inc. (United States)
  • Deep Genomics (Canada)
  • Cloud Pharmaceuticals (United States)
  • Insilico Medicine (United States)
  • BenevolentAI (United Kingdom)
  • Exscientia (United Kingdom)
  • Cyclica (Canada)
  • BIOAGE (United States)
  • Numerate (United States)
  • NuMedii (United States)
Additional players considered in the study are as follows:
Envisagenics (United States) , TwoXAR (United States) , OWKIN, Inc. (United States) , XtalPi (United States) , Verge Genomics (United States) , BERG LLC (United States)
Select User Access Type

Key Highlights of Report


Nov 2019 233 Pages 92 Tables Base Year: 2020 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Artificial Intelligence (AI) in Drug Discovery Market Quantitative research analysis
Global Artificial Intelligence (AI) in Drug Discovery Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Artificial Intelligence (AI) in Drug Discovery Market Report?

Have a Query? Click Here

Other Related Reports

Cardiology Information System Comprehensive Study by Type (CVIS, C-PACS), Application (Catheterization Lab CVIS Solutions, Echocardiography Lab CVIS Solutions, Electrophysiology Lab CVIS Solutions, N...
$ 3750
Solvent Evaporation Comprehensive Study by Type (Rotary Evaporators (Small Volume Rotary Evaporators, Large Volume Rotary Evaporators), Centrifugal Evaporators, Nitrogen Blowdown Evaporators, Spiral ...
$ 3750
Neurofeedback Comprehensive Study by Type (Traditional Neurofeedback, QEEG Loreta Neurofeedback), Application (Neurocare Clinics, Hospitals, Training Institutes, Scientific Research, Others), Functio...
$ 3750
Advanced (3D/4D) Visualization Systems Comprehensive Study by Application (Cardiology, Neurology, Oncology, Other), Platform (Ultrasound AVS, Magnetic Resonance Imaging AVS, Computed Tomography AVS, ...
$ 3650
Prenatal Screening Test Comprehensive Study by Type (Screening Tests (Blood Test, Ultrasound Test), Diagnostic Tests (Amniocentesis Test, Chorionic Villus Sampling Test)), Test Stages (First Trimeste...
$ 3750
Clinical Data Analytics in Healthcare Comprehensive Study by Type (Software, Services), Application (Quality Improvement and Clinical Benchmarking, Clinical Decision Support, Regulatory Reporting and...
$ 3750